Entrada Therapeutics (TRDA) Other Non-Current Assets (2022 - 2025)
Historic Other Non-Current Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $4.0 million.
- Entrada Therapeutics' Other Non-Current Assets changed 0.0% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $4.0 million for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Entrada Therapeutics reported Other Non-Current Assets of $4.0 million as of Q3 2025, which was down 0.0% from $4.0 million recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Other Non-Current Assets registered a high of $13.8 million during Q1 2023, and its lowest value of $4.0 million during Q1 2022.
- Over the past 4 years, Entrada Therapeutics' median Other Non-Current Assets value was $4.0 million (recorded in 2022), while the average stood at $4.7 million.
- As far as peak fluctuations go, Entrada Therapeutics' Other Non-Current Assets surged by 25045.57% in 2023, and later plummeted by 7146.57% in 2024.
- Quarter analysis of 4 years shows Entrada Therapeutics' Other Non-Current Assets stood at $5.2 million in 2022, then decreased by 24.18% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024, then changed by 0.0% to $4.0 million in 2025.
- Its last three reported values are $4.0 million in Q3 2025, $4.0 million for Q2 2025, and $4.0 million during Q1 2025.